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It has been proposed that C-terminal motifs of the
catalytic subunit of budding yeast polymerase (pol) e
(POL2) couple DNA replication to the S/M checkpoint
(Navas, T. A., Zheng, Z., and Elledge, S. J. (1995) Cell 80,
29–39). Scanning deletion analysis of the C terminus
reveals that 20 amino acid residues between two puta-
tive C-terminal zinc fingers are essential for DNA repli-
cation and for an intact S/M cell cycle checkpoint. All
mutations affecting the inter-zinc finger amino acids or
the zinc fingers themselves are sensitive to methylmeth-
ane sulfonate and have reduced ability to induce RNR3,
showing that the mutants are defective in the transcrip-
tional response to DNA damage as well as the cell cycle
response. The mutations affect the assembly of the pol e
holoenzyme. Two-hybrid assays show that the POL2
subunit interacts with itself, and that the replication
and checkpoint mutants are specifically defective in the
interaction, suggesting (but not proving) that direct or
indirect dimerization may be important for the normal
functions of pol e. The POL2 C terminus is sufficient for
interaction with DPB2, the essential and phylogeneti-
cally conserved subunit of pol e, but not for interaction
with DPB3. Neither Dpb3p nor Dpb2p homodimerizes in
the two-hybrid assay.
Yeast mutants with defects in S phase progression normally
arrest their cell cycles before entering mitosis. This arrest is
attributed to a surveillance mechanism, called the S/M check-
point pathway, that prevents inappropriate segregation of un-
replicated or damaged chromosomes by monitoring some as yet
ill defined aspect of chromosome structure. In the presence of
damage, a signal is generated and transmitted either to the cell
cycle apparatus, resulting in inhibition of cell cycle progression,
or to the cellular transcription apparatus, resulting in induc-
tion of functions that participate in repair of the defect and/or
delay cell cycle progression (1). In addition to the S/M check-
point pathway, there are at least three other checkpoint path-
ways that have the replication apparatus either as a target of
inhibition (G1/S) or as a sensor of aberrant function (S/M) or
both (intra-S) (2–4). However, information about the mecha-
nism linking DNA replication and either the cell cycle appara-
tus or the transcription apparatus in these checkpoints has
been limited. Several years ago, it was shown that certain DNA
replication initiation mutants, in addition to failing to enter S
phase, also fail to establish the S/M checkpoint (5, 6). Such
mutants, rather than arresting the cell cycle, progress into
mitosis with unreplicated chromosomes, divide and die. It was
proposed that assembly of the replication apparatus may be
required to establish the checkpoint and that one or more
component(s) of the assembled apparatus monitors the com-
pleteness of replication and sends an inhibitory signal to the
cell cycle apparatus when there is unreplicated (or damaged)
DNA (7). In keeping with this model, several mutants affecting
proteins in the replisome were recently shown to be defective in
the S/M checkpoint: rfc2, rfc5, dpb11, and pol2 (8–12). POL2
encodes the essential DNA polymerase, pol1 e, and Rfc2p,
Rfc5p, and (probably) Dpb11p are polymerase accessory pro-
teins. Thus, an enzyme that was originally thought to have an
essential housekeeping function also seems to have an impor-
tant regulatory function in the cell cycle. This dual function
may form an important paradigm for other checkpoint
pathways (13, 14).
The first checkpoint-deficient allele of pol2 was identified in
a screen for mutants defective in a transcriptional response
observed when hydroxyurea is used to block DNA replication
(15). (Hydroxyurea blocks DNA synthesis by inhibiting precur-
sor biosynthesis and thus depleting nucleotide pools.) Wild-
type cells treated with HU respond by inducing the RNR3 gene,
but one mutant, dun2 (damage uninducible), was deficient in
induction (9). Cloning of the DUN2 gene showed that it was
identical to POL2. Two pol2 mutants temperature-sensitive for
DNA replication and DNA repair (16, 17) also turned out to be
defective in the transcriptional response to DNA damage (9,
15). What was really interesting, however, was that the latter
two mutants were also defective in the cell cycle response to
HU inhibition, since they entered mitosis with incompletely
replicated chromosomes. Further work showed that the Pol2
DNA damage response pathway appears to function in parallel
to the Rad9 pathway and be specific for damage incurred or
encountered during S phase (10). POL2 seems to act upstream
of RAD53, a protein kinase that is one of the central signal
transducers in both the transcriptional and cell cycle responses
to DNA damage, and therefore POL2 has been proposed as a
sensor of DNA damage and stalled replication forks. We have
been interested in identifying new mutants affecting POL2 to
further define the mechanism by which pol e participates in the
S/M checkpoint.
pol e is one of three essential DNA polymerases in yeast (16,
18, 19). pol e is highly homologous to the other essential DNA
polymerases, pol d and pol a, in the catalytic domains, which
have been shown to fall in the N-terminal and central portion
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of the proteins (20). The temperature-sensitive mutants, pol2–9
and pol2–18, have mutations in the conserved catalytic polym-
erase domain, M643I and P710S, while mutations at Asp-290
and Glu-292 reduce the exonuclease proofreading activity and
affect the fidelity of the polymerase (19). The Dun2, DNA
damage response-defective pol2 mutants described above all
map to the C terminus, while the N-terminal pol2–9 and
pol2–18 mutants are proficient in the checkpoint. pol1 and pol3
mutants, defective in DNA polymerases a and d, respectively,
have constitutively elevated expression of the damage induci-
ble genes, rather than a defect in induction (15).
What is special about the pol e C terminus that could be
important for both DNA replication and DNA damage sensing?
Interestingly, the C-terminal region of pol e is essential in vivo,
though far removed from the catalytic domains (9). In vitro,
however, the C-terminal mutants show nearly normal DNA
polymerase activity (16). The catalytic site mutants, pol2–9 and
pol2–18, show interallelic complementation with the C-termi-
nal domain mutants, pol2–11 and pol2–12. It has been sug-
gested therefore that the C- and N-terminal domains have two
independent functions or that pol e dimerizes and heterodimers
are active. The most obvious structural feature of the C termi-
nus is a cysteine-rich region, with two putative zinc finger
motifs (ZF1 and ZF2, Fig. 1). The Dun2 mutants, pol2–11 and
pol2–12, map 11 and 15 amino acids downstream of this region
(9, 16). Since they are nonsense codons their phenotype could
be due directly to loss of critical motifs within the downstream
amino acids or to an indirect effect on the structure of the
near-by cysteine-rich region (see Fig. 1). To identify the specific
amino acids involved in sensing the replication block and DNA
damage and the mechanism by which they induce the cell cycle
and transcription responses, we constructed a series of site
specific deletion mutants near the C terminus of pol e. Here, we
demonstrate that a cluster of 20 amino acid residues between
the two putative zinc fingers is essential for replication in vivo
and the S/M checkpoint. Using the yeast two-hybrid assay for
protein/protein interaction, we discovered that the C terminus
of pol e can self-interact and that the replication- and check-
point-defective mutants are also defective in the interaction.
The C-terminal region is sufficient for interaction with Dpb2p,
the second largest subunit of pol e, and the mutations that
abolish self-interaction also affect Dpb2p interaction.
EXPERIMENTAL PROCEDURES
Materials—plitmus39 vector and M13KO7 phage were from New
England Biolabs. pRS314 TRPARS1CEN4 vector was from the labora-
tory collection (21). pZZ2, carrying RNR3-lacZ was provided by Dr.
Stephen Elledge (Baylor College of Medicine, Houston, TX). Restriction
enzymes, T4 DNA ligase, Vent DNA polymerase, and Klenow large
fragment were obtained from New England Biolabs. Mutagenesis kit
was from Bio-Rad. All the oligonucleotides were synthesized by the
oligonucleotide facility at Caltech. a factor, HU, MMS, ortho-nitrophe-
nyl-b-D-galactopyranoside, ampicillin, and kanamycin were from
Sigma. Plasmid preparation kits were from Qiagen. Standard medium
for growth of bacteria and yeast was from Difco. pAS2–1 (binding
domain) and pACT2 (activation domain) yeast two-hybrid vectors,
Gal4BD antibody, and Gal4AD antibody were obtained from CLON-
TECH. ECL Western blotting reagents and nitrocellulose membrane
were from Amersham Pharmacia Biotech. Monoclonal 12CA5 antibod-
ies for the hemagglutinin epitope were prepared at Caltech. Monoclonal
rat anti-tubulin antibody (clone YOL1/34) was from Accurate Chemical
and Scientific Corp. Fluorescein-conjugated, goat anti-rat IgG second-
ary antibody was obtained from ICN Corp. Polyclonal antibody for the
pol e holoenzyme complex was provided by Dr. Akio Sugino (Osaka
University, Osaka, Japan).
Bacterial and Yeast Strains—Escherichia coli CJ236 dut-1, ung-1,
thi-1, relA1; pCJ105(Cmr) was provided in the Bio-Rad mutagenesis kit.
For routine cloning, the DH5a bacterial strain was obtained from Life
Technologies, Inc. Yeast strains are listed in Table I.
Mutagenesis and Subcloning—pSEY18 vector containing the full-
length POL2 gene cloned at the SacI site (16) was digested with BsrGI,
and the C-terminal POL2 fragment (;2.3 kb) was purified. The purified
C-terminal fragment was subcloned at the BsrGI site in the pLitmus 39
phagemid vector (pLitPOL2). The linearized pSEY18 vector containing
the N terminus of the POL2 was self-ligated and digested with SacI,
and the POL2 fragment was purified. It was then subcloned in the
pRS314 vector (pRPOL2). pLitPOL2 was transformed into CJ236 E. coli
strain, and transformed cells were infected with M13KO7 phage. Ura-
cil-phagemid DNA template was prepared, and mutagenesis was per-
formed according to instructions of the supplier (Bio-Rad) with some
modifications. Briefly, the mutagenic oligonucleotide was annealed to
the uracil-containing DNA template by first heating at 70 °C for 3 min
and then slowly cooling to 30 °C for 1 h. The polymerization mix, T4
DNA ligase and T7 DNA polymerase were added to the annealed
template and incubated on ice for 5 min, at room temperature for 5 min,
and then at 37 °C for 4 h. The reaction was stopped by adding 17 ml of
13 TE buffer. 3 ml of the final mixture was transformed into DH5a cells.
The DNA was prepared from the transformants and sequenced using
automated sequencing at the Caltech DNA sequencing facility. The
oligonucleotides used for the mutagenesis are as follows: D2213–2222,
59-GCG TTA TAT ACT GCT TAC TCA TAT ATC AAA ACC GTA ATA




YHA1 MATa/MATa POL2/pol2–3::LEU2 LEU2–3, 112/LEU2–3, 112 ura3–52
trp1–289 ade5–1/ADE5
(19)
A1128 MATa ade5–1 leu2–3, 112 ura3–52 trp1–289 pol2–3::LEU2 [YEpPOL2] This study
YHA301 MATa ade5–1 leu2–3, 112 ura3–52 pol2–3::LEU2 [YCppol2–18] (19)
YRD1 A1128/pk1 This study
YRD2 A1128/pk2 This study
YRD3 A1128/pk3 This study
YRD4 A1128/pk4 This study
YRD5 A1128/pk5 This study
YRD6 A1128/pk7 This study
YRD7 A1128/pk8 This study
YRD8 A1128/pk9 This study
YRD9 A1128/pk10 This study
YRD10 A1128/pk11 This study
YRD11 A1128/pk12 This study
YRD12 A1128/pk13 This study
PJ69–4A LYS2::GAL1-HIS3, GAL2-ADE2, met2::GAL7-lacZ (29)
SS111–2-11 MATa, trp1–289, ura3–12, ade2–101, gal2, can1, pol2–11 (16)
SS111–2-12 MATa, trp1–289, ura3–12, ade2–101, gal2, can1, pol2–12 (16)
TC102–2-11 MATa, leu2, ura3–52, can1, pol2–11 (16)
TC102–2-12 MATa, leu2, ura3–52, can1, pol2–12 (16)
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AAA CAC ATT TAA CTT TTG-39; D2193–2197, 59-C TTG CTT AAA
CAC ATT TAA TTC TCT GGG GAG AGTTCC-39; D2183–2192, 59-ATT
TAA CTT TTG AAC AAT GCT GGC ACA TGG ACA GTG GGC AC-39;
D2173–2182, 59-GAG AGT TCC TTC CCA CGC GCC ACG TTT CAC
TTT ATG ACA TCT G-39; D2163–2172, 59-CAG TGG GCA CTC ATA
TAG TCC AAA TCT TGA ATT AAA TAG G-39; D2153–2162, 59-CTT
TAT GAC ATC TGG AGC ATC TAG AAC GTA GTT TTT GAA TCA
G-39; 2143–2152, 59-GAA TTA AAT AGG ATT CGA TAT CCA ACA
ATA CTT GAT TAA AGG C-39; D2133–2142, 59-GTT TTT GAA TCA
GGT GTT CTT GTC TGA CGC ATG AAA AAA TAG-39; D2123–2132,
59-C TTG ATT AAA GGC TTT GTG ACA TGC CTT ACA AAA GTC AAT
ATC-39; D2113–2122, 59-GAA AAA ATA GAT TCA GGA GCA AAA CAG
TAT TCA CAT AAA AAA TC-39; D2103–2112, 59-CAA AAG TCA ATA
TCA GAA ATG AAC ACG AGA CTA AAA CTT GGA TC-39; R2163-
STOP, 59-GAC ATC TGG ATT ATC TCA AAT CTT G-39; R2151-STOP,
S2152-STOP, 59-GA TTC GAT ATC TCA TCA TAG TTT TTG AAT C-39;
V2103-STOP, 59-CCA TAA AAA GGA TCC TTA CAC GAG-39; F2093-
STOP, K2094-STOP, 59-CAA ACT TGG ATC TCA TCA TTC CGC TAC-
39; D2192-STOP, 59-G AAC AAT GCT TTA TCT GGG GAG-39 (pol2–11);
Q2196-STOP, 59-C ATT TAA CTT TTA AAC AAT GC-39 (pol2–12);
P710S, 59-GTT TTT GTT GGA AA AGT CTC ATT-39 (pol2–18).
The full-length POL2 gene was reconstituted by subcloning the mu-
tant pol 2 C terminus fragments into the pRPOL2 vector at the BsrGI
site. The recombinants were screened using colony hybridization. The
orientation of the cloned insert was confirmed using MfeI digestion and
by DNA sequencing. pol2–11, pol2–12, and pol2–18 were made by site-
directed mutagenesis to ensure that the phenotype of the original
mutations was due to the single base pair changes found in the original
mapping. The plasmids are listed in Table II. The size of the expressed
proteins was determined by Western blotting after subcloning the C-
terminal regions into the two-hybrid assay vectors described below.
These experiments verified that the stop codons introduced were effec-
tive in truncating the proteins at the desired positions.
Plasmid Shuffling—The plasmid shuffling assay was done as de-
scribed (16, 22). The pol2D strain containing wild-type POL2 on a URA
vector (pSEY18) was transformed with wild-type and mutant genes in
the pRS314 Trp1 vector (pk series plasmids). Transformants were
assayed for viability on synthetic agar plates lacking tryptophan in the
presence of 5-FOA at 24 °C and 37 °C.
Sensitivity of pol2 Mutants to MMS—Fresh YPD agar plates were
made with MMS with varying concentration. The pol2 mutant yeast
strains (see Fig. 1) were grown at 24 °C to saturation in YPD medium,
washed in sterile water, then serially diluted in 10-fold steps to 1023.
Samples (5 ml) of each dilution were placed on the MMS plates and
incubated at 24 °C for 4 days.
Induction of RNR3 Expression in the Presence of MMS—The pol 2
yeast strains were transformed with pZZ2, which carries RNR3-lacZ
(15). The yeast strains containing the RNR3-lacZ reporter were grown
at 24 °C in selective medium until the A600 reached 0.6. The culture was
divided in two equal halves. To one part, MMS was added to a final
concentration of 0.01%. Both cultures were grown for another 6 h at
24 °C. The cells were washed once with water, and then b-galactosidase
assays were carried out as per instructions (CLONTECH Matchmaker
two-hybrid system manual).
Yeast Two-hybrid Protein-Protein Interaction Assay—Gal4-binding
domain (Gal4-BD) plasmid pAST2–1 and Gal4-activation domain
(Gal4-AD) plasmid pAST2–1 (Matchmaker two-hybrid system; CLON-
TECH) were used for cloning of the various genes. The PJ69–4A yeast
strain (23) with three different reporters (ADE2, HIS3, lacZ), each
under the control of a different promoter (GAL2, GAL1, and GAL7) was
used for assessing the protein-protein interactions. To clone the C
terminus (aa 1265–2222) of POL2 in frame with the Gal4BD or
GAl4AD, PCR was performed using primers with flanking NcoI and
BamHI sites. pK series plasmids (see Table II) containing the full-
length wild-type and mutant pol2 genes were used as the DNA tem-
plate. Vent DNA polymerase was used for the PCR reactions. PCR
products were purified from gels and ligated to NcoI/BamHI-digested
Gal4-BD and Gal4-AD vectors. The in-frame sequence near the N
terminus was confirmed by sequencing.
The PJ69–4A yeast strain was co-transformed with the Gal4-BD and
Gal4-AD fusion constructs using the polyethylene glycol/lithium acetate
method. Transformed cells were selected on Trp2/Leu2/Ade2 synthetic
agar plates at 30 °C for 4 days. Transformed cells were further screened
on Trp2/Leu2/His2 synthetic agar plates containing 1 mM 3-amino-
1,2,4-triazole at 30 °C for 3 days. Finally, the cells that grew on both
Trp2/Leu2/Ade2 and Trp2/Leu2/His2 plates were quantitatively tested
for b-galactosidase activity as per instructions (CLONTECH). The units
of b-galactosidase activity were calculated according to b-galactosidase
activity 5 1000 3 A420/(t 3 v 3 A600), where t 5 time (min) required for
the reaction and v 5 0.1 3 concentration factor. To verify the expression
of the Gal4-BD and Gal4-AD (with HA epitope on the N terminus)
fusion proteins, Western blots were prepared using whole cell extracts
as the source of protein and Gal4-BD antibody and 12CA5 antibodies,
respectively, as probes.
DPB2 (24) and DPB3 (25) were cloned by PCR using yeast genomic
DNA as a template, and expression was verified using 12CA5 antibody
and polyclonal antibody to Dpb2p and Dpb3. The sequence of the
oligonucleotides is shown below: DPB2, R1 (59-CTT TAA AGT TTG GCC
ATG GAA CTA G-39) and R2 (59-G TTC TTA TTT GGA TCC ATT ATT
TAG-39); DPB3, R3 (59-C GGG CGC GCC ATG GAA ATG TCC AAC-39)
and R4 (59-GTA CCG CAT GGA TCC AGA TCA C-39).
RESULTS
Amino Acid Residues between ZF1 and ZF2 in the C Termi-
nus of pol e Are Essential for Viability—In order to better
understand the molecular details of the C terminus of pol e
required for its role in DNA replication and damage sensing,
we constructed a panel of deletion mutants covering the C-
terminal 120 aa of the Pol2p protein and studied various phe-
notypes. (For clarity, we will refer in the text to the amino acid
motifs in the region as they are defined in Fig. 1, although
there are no structural data to support the designation “zinc
finger” as yet.) Each mutant (Fig. 1, A–L) contains a deletion of
10 amino acids. Mutants A, B, C, and D have deletions in ZF1;
mutants E and F have deletions between ZF1 and ZF2; mu-
tants G and H have deletions in ZF2; and mutants I, J, K, and
L have mutations in the extreme C terminus of pol e. The
previously studied pol2–11 and pol2–12 nonsense alleles fall in
the region covered by deletion J. In addition to the deletion
mutations, pol2–11, pol2–12, and pol2–18 were remade by site-
directed mutagenesis to ensure that the phenotype of the orig-
inal mutations was due to the single base pair changes found in
the original mapping. We first examined the ability of the
mutants to complement a pol2D strain using a plasmid shuf-
fling assay (16, 22). The mutant genes, cloned on a plasmid
carrying a TRP selection marker, were transformed into a
pol2D yeast strain, which was kept alive by the presence of a
wild-type POL2 gene on a URA plasmid. Transformants were
analyzed for growth at 24 °C and 37 °C on synthetic agar me-
dium containing 5-FOA, which is toxic to Ura1 cells and there-
fore selects against cells carrying the wild-type POL2 plasmid
(Fig. 1). Among the mutants studied, mutants E and F showed
a drastic growth defect when present as the only copies of the
pol2 gene in the cells. Mutant E was unable to support growth
at any temperature, while mutant F was viable at 24 °C but
inviable at 37 °C. Mutant F also grew slower than wild-type
and was enlarged at 24 °C. Mutants A, B, C, and D showed a
TABLE II
Plasmids
Plasmid Relevant genotype Mutant Baseplasmid
pk1 TRP1 ARS4 CEN6 POL2 pRS314
pk2 TRP1 ARS4 CEN6 pol2(D2103–2112) A pRS314
pk3 TRP1 ARS4 CEN6 pol2(D2113–2122) B pRS314
pk4 TRP1 ARS4 CEN6 pol2(D2123–2132) C pRS314
pk5 TRP1 ARS4 CEN6 pol2(D2133–2142) D pRS314
pk6 TRP1 ARS4 CEN6 pol2(D2143–2152) E pRS314
pk7 TRP1 ARS4 CEN6 pol2(D2153–2162) F pRS314
pk8 TRP1 ARS4 CEN6 pol2(D2163–2172) G pRS314
pk9 TRP1 ARS4 CEN6 pol2(D2173–2182) H pRS314
pk10 TRP1 ARS4 CEN6 pol2(D2183–2192) I pRS314
pk11 TRP1 ARS4 CEN6 pol2(D2193–2197) J pRS314
pk12 TRP1 ARS4 CEN6 pol2(D2203–2212) K pRS314
pk13 TRP1 ARS4 CEN6 pol2(D2213–2222) L pRS314
pk14 TRP1 ARS4 CEN6pol2(F2093-TAA) pRS314
pk15 TRP1 ARS4 CEN6pol2(R2151-TAA) pRS314
pk16 URA3 ARS4 CEN6(pol2–18) pRS316
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marginal decrease in viability while mutants G, H, I, J, K, and
L had no detectable growth defect. The results show that the
mutations between ZF1 and ZF2 are critical for the essential
role of pol e in the cell.
Mutants pol2–18 and pol2–11, with N- and C-terminal mu-
tations, respectively, show interallelic complementation of
their growth defect (9). Mutant F was therefore tested for
complementation of pol2–18 (and pol2–11) strains. Plasmid
pk16 (pol2–18) was transformed into strain A1128/pk7 (pol2-
F). Transformants were obtained but grew slowly at 37 °C,
producing cultures that consisted of about 70% viable cells.
Thus, pol2-F and pol2–18 showed partial complementation.
Neither mutant E nor mutant F complemented strain
SS111pol2–11. Mutants A to D and G to L complemented
pol2–11, as expected, since they themselves had only slight
growth defects.
Mutant F Is Defective in the S/M Checkpoint—Cells defec-
tive in the S/M phase checkpoint progress into mitosis with
incompletely replicated DNA resulting in rapid loss of cell
viability. To address the role of the region between ZF1 and
ZF2 in the S/M checkpoint, mutant F was examined for viabil-
ity, DNA content, and nuclear and spindle morphology after
incubation at the nonpermissive temperature. Wild-type and
mutant F cells were grown to log phase at 24 °C and trans-
ferred to 37 °C, and samples of cells were collected at various
time intervals and plated at 24 °C. As expected for a checkpoint
defect, mutant F showed a 70% loss in viability compared with
wild-type after 2 h at 37 °C, and 90% of the cells were dead
after 4 h (Fig. 2A). The DNA content of the cells was also
monitored at each time point. Mutant F cells accumulate in S
phase (70%) and G2 (30%) at 24 °C, which indicates a defect in
S phase progression even at the permissive temperature (Fig.
2B, 0 h). After 2 h at 37 °C, when the cell viability had dropped
drastically, most cells revealed a DNA content between 1C and
2C, indicating a block in S phase. Nevertheless, about 40% of
the cells had fragmented DNA or nuclear bodies (Fig. 2C) and
partially elongated spindles (Fig. 2C). After 4 h, some cells had
apparently undergone an abnormal mitosis as cells were pres-
ent with both 1C and greater DNA content and again spindles
were elongated and nuclei fragmented (Fig. 2C). Loss of viabil-
ity and spindle elongation in the presence of unreplicated DNA
are two phenotypes associated with a defect in the S/M
checkpoint.
Since HU prevents cells from completing replication, HU can
be used to monitor S/M checkpoint defects. Cells with an intact
checkpoint arrest with short spindles and do not enter mitosis
when treated with HU, thus recovering when HU is removed.
Checkpoint mutants are supersensitive to HU because they
enter mitosis with unreplicated DNA. The mutant strains were
streaked on YPD plates containing 150 mM HU and incubated
at 24 °C. Mutant F and pol2–11 were inviable in the presence of
HU even at 24 °C. Among the other mutants, A through D
showed growth retardation, while the remaining pol2 mutants
did not show a significant growth defect relative to wild-type
FIG. 1. Site-specific mutagenesis in
the C terminus of POL2. The drawing
shows the C terminus of POL2 containing
two putative zinc fingers. The pol2 mu-
tants were generated by using Kunkel’s
method as described in Experimental Pro-
cedures. Each site-specific mutant (A-L)
contains a deletion of 10 consecutive
amino acid residues as indicated. To test
the effect of pol2 mutations, the pRS314
(Trp, CEN) vector containing the mutant
pol2 genes (pk plasmids listed in Table II)
was transformed into the strain A1128
pol2–3::LEU2 [YEpPOL2], a haploid de-
rivative of strain YHA1 at 24 °C. The
transformants were replica plated onto
agar plates lacking tryptophan and con-
taining 5-FOA and incubated at 24 °C and
37 °C for 3–4 days. The symbols 111,
11, 6, - refer to normal growth, slow
growth, very slow growth and no growth,
respectively. The position of mutations E
and F, between the two putative zinc fin-
gers, is highlighted by a box.
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(data not shown).
Because of its supersensitivity to HU, mutant F was further
examined for viability, DNA content, and nuclear and spindle
morphology after treatment with HU at the nonpermissive
temperature. Wild-type and mutant F cells were arrested in
the G1 phase using a-factor. They were then shifted to 37 °C,
and half of the culture was incubated in the continued presence
of pheromone while the other half was released from the G1
block in the presence of HU (26). Fig. 3A shows that mutant F
incubated at the nonpermissive temperature during a sus-
tained G1 block retains viability. Thus, entry into S phase
seems to be required to observe loss of viability (compare Figs.
2A and 3A). In contrast, mutant F cells released from the G1
block and allowed to proceed into a synchronous S phase in the
presence of HU at the nonpermissive temperature show a sig-
nificant loss of viability compared with wild-type (Fig. 3B).
Flow cytometric analysis of mutant and wild-type cells treated
in the same fashion showed that both wild-type and mutant F
cells were efficiently blocked in the S phase (DNA content
between 1C and 2C) 4 h after release from the a-factor block
into HU (Fig. 3C). Indirect immunofluorescence demonstrated
that 60–70% of the mutant F cells had partially elongated
spindles after 4 h in HU at the nonpermissive temperature
(Fig. 3D), despite failure to complete replication (Fig. 3C),
whereas wild-type cells showed no spindle separation (Fig. 3D).
Asynchronous cultures of mutant F treated with HU also lose
viability (Fig. 3B). Thus, there is a correlation between spindle
elongation and loss of viability, indicative of a defective S/M
checkpoint. This defect is observed only in cells incurring dam-
age during S phase, but not in cells that are arrested in G1,
consistent with the results obtained for pol2–11 (10). When
released from a-factor block at the permissive temperature,
mutant F did not show a significant loss in viability, even in the
presence of HU (data not shown), which is consistent with the
fact that the previously studied pol2–11 also has a greater
defect in the S/M checkpoint at elevated temperature (10). We
conclude that mutant F is defective in the checkpoint pathway
that monitors damage due to reduction of nucleotide pools as
well as damage due to a thermolabile DNA polymerase at the
nonpermissive temperature.
Mutations in ZF1 and between ZF1 and ZF2 Are Sensitive to
Growth in the Presence of MMS—In order to study the effect of
the pol2 mutations on the DNA damage response, ability to
tolerate MMS damage was monitored by examining growth of
pol2 mutants during chronic exposure to MMS. The mutants
were grown to saturation at the permissive temperature, and
various dilutions were placed on plates containing different
concentrations of MMS. pol2–11 and mutants A, B, D, and F
showed greater sensitivity to 0.025% MMS in comparison to
wild-type and mutants G and H at the permissive temperature
(Fig. 4A). At 37 °C, mutants G and H also displayed MMS
sensitivity (Fig. 4B). The results suggest that ZF1 and amino
acid residues between ZF1 and ZF2 play a primary role in MMS
sensitivity, while ZF2 may have a secondary role. It should be
noted that the N-terminal pol2–18 mutant was also sensitive to
MMS, which may reflect a defect in the repair machinery itself,
since pol2–18 mutants have been shown previously to be pro-
ficient in the checkpoint (Ref. 9; see also Fig. 5).
Mutations in ZF1 and between ZF1 and ZF2 Show Reduced
Inducibility of RNR3 Expression in the Presence of MMS—To
investigate whether the MMS sensitivity of the C-terminal
mutants was due to a checkpoint defect, we studied the ability
of the pol2 mutants to induce transcription of RNR3 in the
presence of MMS (9). The mutants were transformed with an
RNR3-lacz reporter plasmid, and the expression of RNR3 was
assayed. Mutants A, C, and F and pol2–11 showed a reduced
level of RNR3 expression in the presence of MMS (Fig. 5), while
mutants G, H, and L showed a similar level of RNR3 expression
as compared with wild-type POL2. pol2–18 also showed wild-
type levels of induction, as expected. The residual transcription
induction observed in mutants A, C, and F and pol2–11 is
expected and is probably due to the Rad9 pathway. (Elegant
FIG. 2. Behavior of pol2 mutant F at
the nonpermissive temperature. A,
cell viability. Asynchronous POL2 wild-
type and pol2 mutant F cells were grown
at 24 °C in YPD medium (pH 3.9) until
mid-log phase (A600 5 0.6) and then
shifted to 37 °C. Viability was determined
by plating at 24 °C. B, DNA content. Sam-
ples were withdrawn at the indicated
times, fixed in ethanol, digested with
RNase and stained with propidium iodide
(41). C, nuclear and spindle morphology.
After 2 and 4 h, pol2 mutant F cells were
fixed in ethanol (for nuclear morphology)
or formaldehyde (for tubulin morphology).
The nucleoid was observed using 49,6-dia-
mino-2-phenylindole (DAPI), and spindle
morphology was determined using anti-a-
tubulin antibody (9, 42, 43).
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studies have recently dissected the damage response into two
different branches and revealed that the Pol2 pathway re-
sponds to damage only during S phase, whereas Rad9 responds
to damage in other phases of the cell cycle (10).) The results
support the earlier proposal that the zinc fingers in the C
terminus of pol e act as a damage sensor and indicate that ZF1
may play a more important role than ZF2.
Since ZF1 showed greater MMS sensitivity while the inter-
zinc finger mutants E and F showed greater sensitivity to HU,
it seemed possible that the two different motifs might recognize
different types of lesions. However, further examination of
mutant A, which deletes two cysteines of ZF1, showed that it
responded to HU with loss of viability at 37 °C just like mutant
F (compare mutants A and F in Fig. 3B). Thus, ZF1 is not
specific for MMS-induced damage.
Yeast Two-hybrid Assay of Protein Interactions in the C Ter-
minus of POL2 with DPB2 and DPB3—The question now is
how these motifs contribute to the checkpoint. Zinc finger do-
mains have been inferred to play a critical role in protein-
protein interactions (27). To test if the cysteine-rich C terminus
of Pol2p is important for protein-protein interactions in pol e,
we employed the yeast two-hybrid assay (28) and investigated
interactions among the subunits of pol e: Pol2p, Dpb2p, and
Dpb3p. The results are shown in Fig. 6 and Table III and are
summarized in Table IV.
Since it had previously been proposed that pol e might dimer-
ize through the C terminus, we first checked self-interaction
(9). We subcloned the C terminus (aa 1265-end) into two yeast
expression vectors, one such that C terminus was in-frame with
the Gal4 binding domain (pAST2–1) and another such that it
was in-frame with Gal4 acidic activation domain (pACT2). The
pACT2 activation domain vector also has an HA epitope toward
the C terminus of Gal4. Both the vectors were co-transformed
into yeast strain PJ69–4A, a strain that detects weak interac-
tions and minimizes false positives (29). Interaction was as-
sayed by the ability to transcribe three different reporters,
FIG. 3. Cell cycle response of mu-
tant F to HU. A, viability of cells arrested
at 37 °C in the presence of a factor. Cul-
tures of wild-type and mutant F cells were
adjusted to pH 3.9 and were treated with
8 mg/ml a-factor for 2 h at 24 °C. After 2 h,
a factor was added again at 4 mg/ml and
incubation continued for 2 h at 24 °C to
achieve full arrest. The cultures were
shifted to 37 °C and incubation continued
for the indicated times. Additional a fac-
tor was added every 2 h to maintain the
cells in G1. B, viability of mutant F cells
synchronized in G1 and released into S
phase in the presence of HU. For HU
treatment of asynchronous cells, mid-log
phase cells were transferred to YPD me-
dium containing 0.2 M HU and shifted to
37 °C. Viability was determined by plat-
ing on medium lacking HU at 24 °C at
various times as indicated. For synchro-
nous cells, cultures were adjusted to pH
3.9 and were treated with 8 mg/ml a-factor
for 4 h at 24 °C as described previously
(9). (Additional a factor was added after
2 h.) After 4 h, a-factor was removed by
washing. The cells were resuspended in
medium prewarmed to 37 °C and contain-
ing 0.2 M HU. Viability was determined at
the indicated times. Wild-type and mu-
tant A (a ZF1 mutant) were treated in the
same fashion as mutant F for comparison.
C, DNA content of G1 synchronized cells
released into the cell cycle at 37 °C in the
presence of 0.2 M HU. DNA content of the
cells prepared as in panel B was deter-
mined as described in the legend to Fig. 2.
D, nuclear and spindle morphology of
cells from cultures analyzed in panels B
and C. The nuclear morphology was visu-
alized by 49,6-diamino-2-phenylindole
(DAPI), and spindle morphology was visu-
alized using anti-a-tubulin antibodies as
described in the legend to Fig. 2.
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ADE2, HIS3, and lacZ, controlled by three different promoters,
as described under “Experimental Procedures.” The expression
levels of the Gal4 fusion proteins were confirmed by Western
blotting using anti-Gal4 binding domain and anti-HA 12CA5
antibodies. As shown in Fig. 6A, interaction was detected when
the C terminus of pol e was present on both binding domain and
activation domain vectors. The C terminus of pol e was unable
to activate transcription on its own or in combination with
control proteins p53 and T-antigen, suggesting that the self-
association of pol e through C terminus is specific. To localize
the site of self-association, we subcloned various C-terminal
mutants of pol e in both binding domain and activation domain
vectors and assayed for the protein-protein interactions. Dele-
tion of the entire zinc finger region and the extreme C terminus
(D2103-end) abolished interaction, while deletion of ZF2 and
the extreme C terminus (D2163-end) did not, localizing the
effect to the region containing ZF1 and amino acids between
the two zinc fingers. Mutants A and H, with deletions within
ZF1 and ZF2, respectively, showed interaction; but the repli-
cation/checkpoint-defective mutants E and F, with deletions
between ZF1 and ZF2, failed to show any interaction. (Western
blotting confirmed that the proteins were expressed efficiently
(Fig. 6B).) Thus, there is a striking correlation between the
mutants that affect replication and the S/M checkpoint and
those that affect interaction as measured by the two-hybrid
assay. With these experiments it is impossible to determine if
the interaction documented is direct or indirect, however.
We next investigated interaction of Pol2p with the other pol
e subunits. We found that the C terminus interacts strongly
with DPB2 but is not sufficient for interaction with DPB3
(Tables III and IV). Mutants E and F interact with DPB2,
suggesting that the deletions do not cause a catastrophic dis-
ruption of the structure of the entire C-terminal region. How-
ever, quantitation of the interaction by b-galactosidase assay
(Table III) suggests the interaction is weakened by the muta-
tions. Deletions of the extreme C terminus such as are found in
pol2–11 and pol2–12 also fail to abolish interaction with Dpb2p,
but reduce the level of b-galactosidase activity. However, dele-
tion of 30 amino acids between mutant F and mutant J, which
includes ZF2, abolishes interaction. This may be due to a large
structural perturbation, however, since mutants G, H, and I
each appear to interact with DPB2. The interaction between
the POL2 C terminus and DPB2 has been verified by expres-
sion in recombinant baculovirus infected insect cells, as has the
reduced affinity between pol2 mutant E and DPB2.2 Since
mutants E and F interact with DPB2, this may suggest that the
effects on checkpoint are directly due to the mutations in POL2
rather than indirectly due to failure to interact with another
protein in the holoenzyme complex. On the other hand, the
inefficient interaction with mutant E and Dpb2p may suggest
the checkpoint defect reflects faulty assembly of the
holoenzyme.
Neither Dpb2p nor Dpb3p appear to self-interact by the
two-hybrid assay (Table IV).
DISCUSSION
Yeast DNA polymerase e plays an essential role in chromo-
somal replication (16, 18, 19). In recent years, additional roles
of pol e in repair and cell-cycle regulation have emerged (9, 10,
17). Structure-function analysis has suggested that the C ter-
2 R. Dua and J. L. Campbell, unpublished results.
FIG. 4. MMS sensitivity of mutants. Cells were grown to satura-
tion in YPD medium, washed in sterile water, then serially diluted in
10-fold steps to 1023. Aliquots (5 ml) of each dilution were placed on the
MMS plate and incubated at 24 °C (A) and 37 °C (B) for 3–4 days.
FIG. 5. RNR3 expression by pol2 mutants in the presence of
MMS. pol2 mutants were transformed with plasmid pZZ2 encoding the
RNR3-lacZ fusion protein. The cells were analyzed for RNR3 expression
as described under “Experimental Procedures” (9).
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minus of pol e, although far removed from the catalytic domain,
is essential for replication, for repair, and for DNA damage-
induced transcription and cell cycle arrest. It has been pro-
posed that pol e could be involved in the initial recognition and
processing of the DNA damage. How pol e recognizes and
communicates the checkpoint signal downstream to other
member(s) of the transduction machinery is unknown. In this
study, we have begun to illuminate the structural basis for the
checkpoint function of pol e by site-specific deletion mutagen-
esis of the C terminus. We demonstrate that amino acid resi-
dues (mutants E and F) between ZF1 and ZF2 in the C termi-
nus are essential for viability, indicating a role in DNA
replication. Furthermore, the temperature-sensitive pol2 mu-
tant F showed a significant loss in viability at the nonpermis-
sive temperature and had partially elongated spindles when
most of the cells were still in the S phase. The results are
consistent with a role for these inter-zinc finger amino acids in
coupling DNA replication and S/M checkpoint. Although we
measured the checkpoint defects both in the presence and
absence of HU, it is still not clear whether pol e is part of a
signal that restrains mitosis during a normal cell cycle or just
part of the response to replication inhibition, since the check-
point failure is not detectable at permissive temperatures. Re-
cently, D’Urso and Nurse (30), by examining the phenotype of
germinating spores containing a disruption of the cdc201 gene
(encoding pol e from Schizosaccharomyces pombe) showed that,
contrary to expectations from previous studies of the effect of
HU on Saccharomyces cerevisiae pol2 mutants, S. pombe has a
functional S phase checkpoint in the complete absence of pol e.
To explain this behavior, it was proposed that the checkpoint in
the presence of DNA damage by HU might be different than the
checkpoint for the coordination between the S and M phase in
a normal cell cycle. This is entirely possible, since there are
clearly numerous subsets of checkpoint pathways yet to be
defined.
The S/M checkpoint cell cycle arrest pathway and damage-
sensitive transcription induction pathway appear to share
many common regulatory elements (1). pol2–11 and pol2–12
mutants with defects in the S phase checkpoint were also
defective in recognizing MMS-induced DNA damage. rfc5–1
mutants, defective in the DNA polymerase clamp loader, were
also shown to have reduced damage-induced transcription and
a defective S/M checkpoint (11, 31). In the current study, we
show that pol2-F appears to share the same behavior. Mutant
F was very sensitive to MMS and showed reduced RNR3 in-
duction in the presence of MMS, in addition to the cell cycle
TABLE III
Two-hybrid interaction between DPB2 and the POL2 C terminus
All POL2 constructs represent C-terminal fusions beginning at aa
1265, as in Fig. 6.
Bait Prey Ade His b-Gal
units
DPB2 Vector 2 2 2.2
DPB2 DPB2 2 2 ND
POL2(WT) DPB2 1 1 28
DPB2 POL2(WT) 1 1 30
pol2(E) DPB2 1 1 21
pol2(F) DPB2 1 1 ND
pol2(G) DPB2 1 1 ND
pol2(I) DPB2 1 1 ND
pol2–11 DPB2 1 1 20
pol2(D2163-STOP) DPB2 2 2 ND
FIG. 6. Yeast two-hybrid analysis. A,
interactions. The C terminus (aa1265-
STOP) of POL2 was prepared by PCR and
cloned into pAS2–1 binding domain and
pACT2 activation domain vectors as de-
scribed under “Experimental Proce-
dures.” The resulting Gal4 fusion vectors
were co-transformed into strain PJ69–
4A. Ability to grow on medium lacking
adenine or histidine was monitored. The
b-galactosidase activity was measured
using ortho-nitrophenyl-b-D-galactopyr-
anoside as substrate, as described under
“Experimental Procedures.” The activity
is expressed in b-galactosidase units. B,
Western blots of extracts of cells express-
ing mutant E in the binding domain and
activation domain vectors. Fusions in the
binding domain vector were detected with
Gal4 antibody, and fusions in the activa-
tion domain vector were detected with
12CA5 anti-hemagglutinin antibody as
described under “Experimental Proce-
dures.” The band corresponding to mu-
tant E migrates just above the 104-kDa
marker.
TABLE IV
Summary of two-hybrid interactions between the C terminus of POL2
and its subunits, DPB2 and DPB3
Bait Prey Prey Prey
POL2(1265–2222)a DPB2b DPB3b
WT (1265–2222) 1 1 2
A 1 1 2
E 2 1 2
F 2 1 2
G 1 1 2
H 1 1 2
I 1 1 2
2192-STOP(pol2–11) 1 1 2
2163-STOP 1 2 2
2103-STOP 2 ND ND
DPB2 1 2 2
DPB3 2 2 2
a All of the POL2 genes used as prey correspond to the mutants used
as bait; thus, mutant A was tested against mutant A, etc. See also Fig.
6.
b Interactions involving Dpb2p were carried out with DPB2 cloned in
both binding domain and activation domain vectors. Dpb3p interaction
with Pol2p mutants was only tested with DPB3 in the activation do-
main vector, since there was no interaction between Dpb3p and wild-
type Pol2p in either orientation.
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effects discussed. Mutants A, B, C, and D, with deletions in
ZF1, were less sensitive to growth on HU-containing plates
than mutant F, but they were more sensitive to MMS and
showed equivalent reduced expression of RNR3. The sensitiv-
ity toward MMS could also arise due to a direct defect in the
DNA repair machinery, although it seems less likely since
pol2–11 and pol2–12 mutants are proficient in the repair of
MMS-induced damage (32).
Extensive genetic studies and biochemical analysis suggest
that the 1200 C-terminal amino acids of POL2 contain sites
that stabilize subunit interactions in the pol e holoenzyme
complex (8, 18, 24, 25, 33). The data presented in this study
support this by demonstrating interaction between the C ter-
minus of the catalytic subunit and the conserved subunit,
Dpb2p, using the two-hybrid assay. The C terminus is not
sufficient for interaction with Dpb3p. However, the two-hybrid
analysis also suggests that there may be an additional, previ-
ously unsuspected interaction involving this domain. Using
amino acids 1265 to the stop codon of POL2 as bait in the yeast
two-hybrid assay, we found that the C terminus of wild-type pol
e cloned into the activation domain vector can efficiently acti-
vate transcription, whereas mutants E and F were unable to do
so. Since mutants E and F are defective in replication, the
two-hybrid assay results suggest that at least one essential
form of pol e is oligomeric, perhaps a dimer. We do not know if
the interaction requires another yeast protein as a bridge,
however, since two-hybrid assays with yeast proteins cannot
distinguish direct from indirect protein/protein interactions. It
is clear, however, that the same mutations that abolish the
apparent homodimerization also weaken the interaction of
Pol2p with Dpb2p. The proposed oligomerization could explain
several other findings. The interallelic complementation of
pol2–11 and pol2–18 mutants (9), the interallelic complemen-
tation of pol2–18 and pol2-F mutations (this work), partial
complementation of pol2–11 by a C-terminal fragment of POL2
(9), and, in S. pombe, the apparently dominant negative effect
of expression of a mutant pol e in cdc20D germinating spores
(30) could all be explained if pol e acts as a dimer. The possible
dimerization of pol e is also interesting in view of the fact that
the E. coli DNA polymerase III holoenzyme, the essential rep-
licase, forms dimers in solution and acts as a dimer during
coordinated synthesis of the leading and lagging strands (34).
Although it is thought that leading and lagging strand elonga-
tion are coordinated through the use of two different gene
products, pol d and pol e, one on each strand, obviating the need
for dimeric polymerases as are found in prokaryotes, a possible
role for dimeric polymerases in eukaryotes could be coordina-
tion of the two forks emanating from a single origin. The idea
that the two branch points of a bidirectional replication bubble
are connected into a binary replisome was put forward many
years ago as a mechanism to prevent rotation of the two forks
with respect to each other and thus avoid undue tangling of the
daughter chromosomes (35). Dimerization of the polymerases
could both serve to link the two forks physically and to ensure
synchronous activity at both forks. It has previously been sug-
gested that DNA helicases may also have an organizational
role in tethering diverging replication forks to each other (36).
Active replication complexes have been proposed to consti-
tute a device that, once formed, continually sends an inhibitory
signal to the checkpoint machinery to prevent mitosis until the
replication phase (S phase) is faithfully completed (37). Disas-
sembly after completion of replication would then allow mito-
sis. At which point in assembly is the surveillance mechanism
activated? Does it require unwinding and conversion of the
origin into a replication fork? Mutant F, described here, shows
a correlation between a defective S/M phase checkpoint and
destabilized protein-protein interactions, suggesting that the
proper assembly of the pol e complex within the replication
complex could be important for initiating and/or maintaining
the S phase checkpoint signal. pol e has been shown to be
absent from origin replication complexes early in G1 and to
associate with origin replication complexes late in G1, so the
periodic association of pol e with origins would be consistent
with a role in the checkpoint (38). It is still possible, however,
that the protein-protein interactions are required only for the
replication function of pol e. In fact, in only one case have a
replication defect and a checkpoint defect been (partially) ge-
netically separated. The overexpression of the POL30 gene,
encoding the proliferating cell nuclear antigen was shown to
suppress the replication defect of the rfc5 but not its checkpoint
defect (11).
Another mystery is how the whole assembly of proteins can
sense incomplete DNA replication and DNA damage due to
radiation or chemicals such as MMS in chromosomes undergo-
ing replication. Something in the structure of the DNA itself,
such as stretches of single-stranded DNA formed during repli-
cation and blocks due to DNA damage, has been proposed to act
as a signal in the S phase, and the zinc finger of pol e has been
proposed to monitor the signal (9). Single-stranded DNA has
been shown to act both as an efficient trap for pol e and to
actually promote dissociation of full-length pol e but not a pol e
protein missing amino acids 1270 to the end (aa 2222) from
primer-templates, suggesting that there is a binding site for
single-stranded DNA in the large, non-catalytic C-terminal
region (39). The mutant phenotypes described in this work
suggest that the zinc finger region may be what is critical for
single-stranded DNA sensing in that C-terminal segment. A
damage recognition role has been proposed for zinc fingers in
two other proteins (40). The new checkpoint-defective mutants
will be useful in reconstituting mutant pol e holoenzymes to
further evaluate the physical mechanism of the sensing of DNA
damage using in vitro binding studies and kinetic analysis of
activity on various model substrates.
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